IBB vs. XBIT
IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while XBIT (XBiotech Inc.) is a stock. Over the past 10 years, IBB returned 6.89%/yr vs -15.23%/yr for XBIT. Their 0.30 correlation means their historical movements had little consistent relationship.
Performance
IBB vs. XBIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a 10.55% return, which is significantly higher than XBIT's -6.69% return. Over the past 10 years, IBB has outperformed XBIT with an annualized return of 6.89%, while XBIT has yielded a comparatively lower -15.23% annualized return.
IBB
- 1D
- -1.87%
- 1M
- -4.75%
- 6M
- 8.20%
- YTD
- 10.55%
- 1Y
- 40.47%
- 3Y*
- 13.65%
- 5Y*
- 2.65%
- 10Y*
- 6.89%
- ALL TIME*
- 7.16%
XBIT
- 1D
- -0.45%
- 1M
- -3.04%
- 6M
- -11.16%
- YTD
- -6.69%
- 1Y
- -21.75%
- 3Y*
- -25.25%
- 5Y*
- -32.74%
- 10Y*
- -15.23%
- ALL TIME*
- -17.59%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $252.83M | $308.82M | $278.87M | |
XBIT XBiotech Inc. | $97.46K | $97.91K | $78.84K |
IBB vs. XBIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 10.55% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
XBIT XBiotech Inc. | -6.69% | -39.49% | -1.25% | 13.96% | -68.46% | -17.46% | -16.15% | 267.42% | 28.93% | -61.07% |
Correlation
The correlation between IBB and XBIT is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.27 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.32 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.31 |
Correlation (All Time) Calculated using the full available price history since Apr 15, 2015 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. XBIT — Risk / Return Rank
IBB
XBIT
IBB vs. XBIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | XBIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.50 | ||
| Sortino ratioReturn per unit of downside risk | +3.34 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 0.94 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 4.25 | -0.59 | +4.84 |
| Martin ratioReturn relative to average drawdown | 12.35 | -0.80 | +13.15 |
Loading charts...
Drawdowns
IBB vs. XBIT - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, smaller than the maximum XBIT drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for IBB and XBIT.
Loading charts...
Drawdown Indicators
| IBB | XBIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -92.67% | +29.82% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -39.43% | +29.80% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -78.56% | +53.71% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -87.07% | +47.25% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -90.13% | +50.31% |
Current DrawdownCurrent decline from peak | -5.96% | -91.78% | +85.82% |
Average DrawdownAverage peak-to-trough decline | -21.06% | -70.38% | +49.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.31% | 28.93% | -25.62% |
Volatility
IBB vs. XBIT - Volatility Comparison
The current volatility for iShares Nasdaq Biotechnology ETF (IBB) is 6.14%, while XBiotech Inc. (XBIT) has a volatility of 6.81%. This indicates that IBB experiences smaller price fluctuations and is considered to be less risky than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | XBIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.14% | 6.81% | -0.67% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 18.99% | -3.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.45% | 47.14% | -26.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.12% | 63.83% | -41.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.12% | 73.25% | -50.13% |
Dividends
IBB vs. XBIT - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.22%, while XBIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
XBIT XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IBB and XBIT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBIT has higher volatility (6.81%) compared to IBB (6.14%). In terms of maximum drawdown, IBB dropped -62.85% vs XBIT's -92.67%.
IBB currently has the higher Sharpe Ratio (2.00 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and XBIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer